George L Drusano

18PUBLICATIONS
25CO-AUTHORS
Molecular targetsStochastic analysis and modellingCancer therapy (excl. chemotherapy and radiation therapy)Microbial ecologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Feb 10, 2026
Identifying optimal combination regimens for therapy of Mycobacterium tuberculosis with an algorithmic approach: prospective predictions and validations.

Arnold Louie, Michael Neely, Sarah Kim

|Dec 04, 2025
Analyzing Pharmacodynamic Count Data That Rapidly Decrease to Zero.

Walter M Yamada, Alan Schumitzky, Alona Kryshchenko

|Jan 27, 2025
Translating Pharmacokinetic-Pharmacodynamic Principles Into Improved Methodology for Clinical Trials That Compare Intermittent With Prolonged Infusion of Beta-Lactam Antibiotics.

Alwin M Tilanus, Ryan K Shields, Thomas P Lodise

|Dec 13, 2024
Evaluation of a potent LpxC inhibitor for post-exposure prophylaxis treatment of antibiotic-resistant <i>Burkholderia pseudomallei</i> in a murine infection model.

Henry S Heine, Bret K Purcell, Clayton Duncan

|Aug 12, 2024
Omadacycline is active <i>in vitro</i> and <i>in vivo</i> against ciprofloxacin-resistant <i>Bacillus anthracis</i>.

Henry S Heine, George Drusano, Bret K Purcell

|Mar 18, 2024
Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea.

Magnus Unemo, Daniel Golparian, Joakim Oxelbark

Pageof 3

Frequent Collaborators

7 joint publications

Sarah Kim

6 joint publications

Charles A Peloquin

6 joint publications

Jürgen Bulitta

6 joint publications

Arnold Louie